
Junji Gene is a life sciences company specializing in gene synthesis, oligonucleotide synthesis, gene editing, protein expression, biopharmaceutical safety evaluation, and high-throughput sequencing. They offer integrated, automated, and intelligent technology platforms for these services, aiming to accelerate life science research and empower the synthetic biology industry. The company also provides comprehensive safety evaluation testing for biopharmaceuticals, including nucleic acid drugs, cell and gene therapies, gene editing drugs, and protein drugs, from early research to clinical stages. Junji Gene's mission is to contribute to global health and sustainable development by being a trusted partner in the biopharmaceutical and synthetic biology sectors, focusing on automated and intelligent biotechnology applications.

Junji Gene is a life sciences company specializing in gene synthesis, oligonucleotide synthesis, gene editing, protein expression, biopharmaceutical safety evaluation, and high-throughput sequencing. They offer integrated, automated, and intelligent technology platforms for these services, aiming to accelerate life science research and empower the synthetic biology industry. The company also provides comprehensive safety evaluation testing for biopharmaceuticals, including nucleic acid drugs, cell and gene therapies, gene editing drugs, and protein drugs, from early research to clinical stages. Junji Gene's mission is to contribute to global health and sustainable development by being a trusted partner in the biopharmaceutical and synthetic biology sectors, focusing on automated and intelligent biotechnology applications.